Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
History
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/4f/80/93/4f809386-0ed8-25b6-795f-defacd58a06f/mza_387775605052435779.jpg/600x600bb.jpg
QCast: Data-Driven Dialogue in Drug Development
Quanticate
27 episodes
1 week ago
In this QCast episode, Jullia and Tom unpack how machine learning is being applied across the pharmaceutical industry. They discuss what machine learning means in a regulated drug development context, where it is already supporting discovery, development, and trial operations, and how teams can use these methods responsibly without undermining scientific or regulatory confidence. Key Takeaways Understand how machine learning differs from traditional statistical approaches, and why it is parti...
Show more...
Life Sciences
Science
RSS
All content for QCast: Data-Driven Dialogue in Drug Development is the property of Quanticate and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this QCast episode, Jullia and Tom unpack how machine learning is being applied across the pharmaceutical industry. They discuss what machine learning means in a regulated drug development context, where it is already supporting discovery, development, and trial operations, and how teams can use these methods responsibly without undermining scientific or regulatory confidence. Key Takeaways Understand how machine learning differs from traditional statistical approaches, and why it is parti...
Show more...
Life Sciences
Science
https://storage.buzzsprout.com/2uhez7zllv77yth2pfzol1l6md7j?.jpg
Episode 20: Missing Data in Clinical Trials
QCast: Data-Driven Dialogue in Drug Development
10 minutes
1 month ago
Episode 20: Missing Data in Clinical Trials
In this QCast episode, Jullia and Tom unpack missing data in clinical trials — why it biases effect estimates, how the estimand framework drives prevention and analysis choices, and what good sensitivity work and reporting look like for credible, inspection-ready results. Key Takeaways Define estimands and intercurrent-event strategies, then align follow-up and data collection. Prevent over correct with simpler schedules, remote options, continued follow-up, and early action ...
QCast: Data-Driven Dialogue in Drug Development
In this QCast episode, Jullia and Tom unpack how machine learning is being applied across the pharmaceutical industry. They discuss what machine learning means in a regulated drug development context, where it is already supporting discovery, development, and trial operations, and how teams can use these methods responsibly without undermining scientific or regulatory confidence. Key Takeaways Understand how machine learning differs from traditional statistical approaches, and why it is parti...